Skip to main content
. 2006 Aug 15;3(11):767–775. doi: 10.1098/rsif.2006.0145

Table 2.

Study design and macroscopic observations. (The material numbers refer to those in table 1.)

material 1 2 3 4 5 6 7 8 9 10 total
number of animals 10 10 10 10 10
subcutaneous (s.c.) sites 10 10 10 10 10 50
intramuscular (i.m.) sites 10 10 10 10 10 50
visible nodule development (sites) 0 0 0 0 10 10 0 10 0 0 30
sacrifice or death (animals)
4–5 months 0 0 3a 0 0 3
6 months 4 4 7b 4 4 23
8 months 0 0 0 1a+5b 0 6
12 months 6 6 0 0 6 18
a

Death of the animal.

b

Animals were euthanized because of the development of handicapping tumours.